ã¡ãã£ã¢èšäº
ã€ãã«ã¡ã¯ãã³ã 誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ããºãææ°ããŒã¯ 424
twitterã³ã¡ã³ã 388ä»¶äž 101ïœ200件
ã€ãã«ã¡ã¯ãã³
誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
åããå¹æããããšãããè«æã¯ãšããã³ã¹ã®ã¬ãã«ãä¿¡é ŒåºŠãäœããã®ãã»ãšãã©ã§ä¿¡é ŒåºŠãé«ããšããããã®ã§ãããŒã¿ãããæ¹ã劥åœã§ãªããšã¯èšãããŠãã
æ¥æ¬èªèšäº
1人ã®æ£è
ã®ããŒã¿ãã³ããããŠ,å®éã«ã¯ååšããªãæ£è
ãäœãåºãããããŠããŒã¿æé .
ãããªãã»ã©,ãã£ãªãã³ç¶æ ã ã£ãããã§ãã.
ãããªãã»ã©,ãã£ãªãã³ç¶æ ã ã£ãããã§ãã.
ã€ãã«ã¡ã¯ãã³ãæå¹ãæ害ããªããŠäžè¬äººã«ã¯ããããªããç¥ã£ãŠãç 究è
ãé»ã£ãŠãããã ãªãã³ãããæ²éåããŠãã®ãã¯èª°ãããã£ãŠãªãæ°ããã äžã®äžããããªãããšã ããw
ïŒã€ãã«ãã®äººãŸã§æ¯çã«ãä»®ã«ããå
Œ
±æŸéãããããªãã¡ããã¡ããªãããæµããŠããã®ã ãããïŒåŠåš ãšåºç£ãå°éã®å»åž«ãã¹ã»ããŒãªãŒå士ã¯...
ãBBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªããã
æ°åã³ããã¯ã¯ãã³ãã€ãã«ã¡ã¯ãã³ãå»åŠã®ç£ç©ãªã®ã«ãã©ãããŠãã¯ã¯ãã³ã¯å±éºã§æå¯çè«è¬ãã³ããã«å¹ãïŒããªã©ãšããççŸãä¿¡ããŠããŸããã®ãâŠããåçµãå¹ãããšãã®æ¹ããŸã çãéã£ãŠããã
ãã€ãã«ã¡ã¯ãã³ã» 誀ã£ãç¹å¹è¬ããBBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãã»ãã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
äžéšã®å€ãªæ¹ã
ãæšãã€ãã«ã¡ã¯ãã³ããå¹æãããæ ¹æ èªäœãééã£ãŠããŠå¹æãªããŠãªããšèšãã話ã
ããã¶ãåããå¹æç¡ãäºã¯èšãããŠããããŸã ãããã ããã
Reading:
ããã¶ãåããå¹æç¡ãäºã¯èšãããŠããããŸã ãããã ããã
Reading:
ã¢ãµãææã®ã¡ãã£ã¢ãäœãèšã£ãŠãä¿¡çšãªããŠå°ã«èœã¡ãŠãã®ã ãâŒïž
åŠå®ããã£ãŠããšã¯ãå¹ããŸããšèšããµãã«è§£éããã ããã
åŠå®ããã£ãŠããšã¯ãå¹ããŸããšèšããµãã«è§£éããã ããã
ãããŸãã«èšãã°ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ãè«æã¯ã©ããä¿¡é Œæ§ãäœãããä¿¡é Œæ§ã®é«ãè«æã§ã¯æå¹æ§ã¯ç€ºãããŠããªãããã€ãŸãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã¯ç¢ºèªãããããšããªãããšããããšãã
ãã®ãã¥ãŒã¹ã®ã³ã¡ã³ãæ¬èŠããšåã¯ã¯ãã³å¢ãçäžããŠãŠé¢çœãã§ãã
ãããããªãã§å¹ããªããŠè©±åºãŠãããã ãããªã
ã€ãã«ã¡ã¯ãã³æœ°ãã®èšäºãåºãã°åºãã»ã©ãå¹ããã ãããªãšæã£ãŠããŸãã
ã€ãã«ã¡ã¯ãã³ã®è¬çïŒå¯çè«ã®ç¥çµæ¯ïŒããèšã£ãŠãæãŠã£ã«ã¹å€ãšããŠã®åãã¯ç¡ãã
ãã®äºã«æ°ã¥ããªã人ãå€ãããã
ãã®äºã«æ°ã¥ããªã人ãå€ãããã
ãã€ãå±ã®ååºæŒã楜ãã¿ã«ããŠããŸãã
ããããªâŠ
ã©ãããŠãããªã£ãâŠ
â
ã©ãããŠãããªã£ãâŠ
â
補è¬äŒç€Ÿã¯å°ã«èœã¡ãã
ã§ã¯ãåŠæ¹ããŠå¹æãå®æããŠããæ¥æ¬ã®å»åž«ã¯åã€ããŠãã®ïŒïŒ
ã人ã
ã«èª€ã£ãå®å¿æãäžããããšã§ãéæ¥çãªå®³ãçã¿åºãå ŽåããããCOVID-19ãžã®å¯Ÿå¿ãšããŠãç
é¢ã«è¡ã£ããã¯ã¯ãã³ãæ¥çš®ãããããã®ã§ã¯ãªããã€ãã«ã¡ã¯ãã³ãéžã¶å ŽåãããŸãã«ããã ãã
ãã€ãã«ã¡ã¯ãã³ã¯æ°åã³ãããŠã€ã«ã¹ææçCOVID-19ã®å¥è·¡ã®æ²»çè¬ãšåŒã°ããã¯ã¯ãã³å察掟ã«æ¯æãããŠããã
ã€ãã«ã¡ã¯ãã³è¯å®æŽŸã¯ããã¯ãå¹æããããã€ãã«ã¡ã¯ãã³ãèªããããããšããç®çã«ãªã£ãŠãããã ãããã
ãã€ãã«ã¡ã¯ãã³ãå¹æããããæ¬çã ãã©ããã¯ã¯ãã³æŽŸãå©æš©ã®ããã«ã€ãã«ã¡ã¯ãã³ãèªããŠãããªãããšãã被害åŠæ³ããããããçµæããªã
ãã€ãã«ã¡ã¯ãã³ãå¹æããããæ¬çã ãã©ããã¯ã¯ãã³æŽŸãå©æš©ã®ããã«ã€ãã«ã¡ã¯ãã³ãèªããŠãããªãããšãã被害åŠæ³ããããããçµæããªã
ããŒ
äžå®ã«ããç£ã¿åºããã誀ã£ãç§åŠãè²ãŠãâŠã ããã
äžå®ã«ããç£ã¿åºããã誀ã£ãç§åŠãè²ãŠãâŠã ããã
ã€ãã«ã¡ã¯ãã³ã¯çç£éããããªã«å€ããªããããšãã§æ°åã³ããã®æ²»çè¬ã ãšãã¬ãã§ãå ±éããã圱é¿ã§äžæ°ã«äžè¶³ããŠæ¬æ¥ã®ææçã§ååãéèŠãªç¥ç¬ã®æ²»çãã§ããªããªã£ããšå»è
ãæ¿æããŠãã
ã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ã€ãã«ã¡ã¯ãã³ã£ãŠç§åŠè
ã¯æçã9å²è¶
ãªã®ã«ãã¹ã³ããç¡çç¢çãè³åŠäž¡è«ãã«ä»ç«ãŠäžããŠãã®ã§ããªã«äººã®ããã«ããŠãã®æã
æ¥æ¬èªçæ¥ã
ã€ãã³ã¡ãžæžããŠãã€ãã«ã¡ã¯ãã³ä¿¡è
ãããäžåèªãã§ãã ããâŠ
> æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ã
#
#
åããŸãããç§åŠæè²ã®å€±æãçãã ãšãã§ãç§åŠã§ãããã¯ã¯ãã³ãæªã ãšããç§åŠçæ ¹æ ãšã瀺ããåã¯ã¯ãã³æŽŸã£ãŠããªãã§ãããã
ããã®è¬ãæšé²ããŠãã人ã
ãæ ¹æ ãšããŠããå€ãã®éèŠãªç 究ã«ã¯ãæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠãããã
åœãåãã人皮ãåããããä¿¡ããããã®ããä¿¡ããªãïŒããšå
¬èšãã人éã«æ£ããæ
å ±ãäŒããã®ã¯è³é£ã®æ¥ã ãªã⊠人åœã«é¢ãã話ãªãã ã⊠<
ã€ãã«ã¡ã¯ãã³ã«åºå·ããäžæ¹ã§æ°ãã«æ²»éšã§å¹æã蚌æãããæ°è¬ã«èŠåããããªã蟺ãã¯ç
ãã§ãæããããäžäººã®äžã§æ°åã³ããåŠå®è«ãšäœµåããŠããããã®ã¯ã³ã³ãããŒã«æ¬²æ±ã®è£è¿ãã ãããã
ããã
ä»ã以ãŠã¯ã¯ãã³ã®åŠå®ãçºä¿¡ãç¶ãã人éã£ãŠãé°è¬è«åæ§ã«å察æèŠã«é¡ããããŠãã人ãéšããŠãããã¿ã€ãºãè¡ãããšãã人ã«ããæããªãã
ã°ãŒã°ã«ã¢ãŒã¹åå£ããã¯ãBBCã«æè°ããã¹ãã§ã¯
ã€ãã«ã¡ã¯ãã³ã£ãŠãªãã§ãããªã«ããã ãããªã®ãã
æšããŠã人ãã¡ãéã«è²¶ããçµæã«ãªã£ãŠãããããšããæããã®ã ãã©ãªã
æšããŠã人ãã¡ãéã«è²¶ããçµæã«ãªã£ãŠãããããšããæããã®ã ãã©ãªã
BBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
äžææãªããå¿
æ»ã«ã€ãã«ã¡ã¯ãã³ã®æå¹æ§ãã¢ããŒã«ããŠãããå»çã®çŽ 人ãã®äººãã¡ãããŸãã§äœäºããªãã£ãããšã®ããã«ç¥ããã·ãããŠããã®æ¬åœã«ç¡è²¬ä»»ã
â¡ïž
â¡ïž
ç§åŠãããããããã ããã
æ£çŽããã®ä»¶ã¯ç¯çœªã ãšæã£ãŠãã
æ£çŽããã®ä»¶ã¯ç¯çœªã ãšæã£ãŠãã
ããããããCOVID-19ã«å¹ãããåè£ã®äžã€ã«éããªãã£ãã®ã«ãå®äŸ¡ã§å
¥ææ§ãè¯ãããããé°è¬è«ãšåã¯ã¯ãã³éåãšçµã³ã€ããçµæãåä»ã§é¢åãªååšã«
ç¥ç¬æ£è ãçç£èŸ²å®¶ã«ãšã£ãŠã¯ããè¿·æ
â
ç¥ç¬æ£è ãçç£èŸ²å®¶ã«ãšã£ãŠã¯ããè¿·æ
â
>BBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ããããã°ãåœå
ã§ãæ²»éšãå§ãŸã£ãã£ãŠãã¥ãŒã¹ã以åãã£ããã©ã©ããªã£ãã®ããªãã
ãã€ãã«ã¡ã¯ãã³ã«é¢ããŠãããŸã§çºè¡šãããç 究ã®äžã§æã倧èŠæš¡ã§è³ªãé«ãã®ã¯ã«ããã»ãã¯ãã¹ã¿ãŒå€§åŠã®ãã¥ã®ã£ã¶ãŒæ²»éšãããããã®ã ããã®ç 究ã§ããCOVID-19ã«å¯Ÿããå¹æã¯äœã確èªãããªãã£ãã
ãŸã ãã€ãã«ã¡ã¯ãã³ãããããšãèšã£ãŠã人ãããã ãªã
ããã«é¢ããŠã¯æ¿æ²»å®¶ãå æ ããŠãããå¿é
ããã«é¢ããŠã¯æ¿æ²»å®¶ãå æ ããŠãããå¿é
äžæ¹çãªèšäºã
ïŒ
ïŒ
ã€ãâŠããŒããã¥ãŒã¹ããã®ããšãããªã«å¥œããããªããã©ããã®èšäºãšã¶ãäžãã£ãŠããã³ã¡ã³ãæ¬ãçºããŠãã倧å€ãã³ãã³ããŠããŸã£ãã®ã§ä»æ¥ãã¡ã«ã¡ã¯åªããããŠãããããšæã
ãµã æ¡ä»¶ã((((ïŒïŸÐïŸ)))))))
åã¯ã¯ãã³æŽŸã®æé å
·åãé
·ããã
ãããªããå æžãªæ ¹æ ã®è¬ã§æ¥æ¬ã¯æ²»éšããã®ïŒããããã ã
>äžçåå°ã§äººã ãã€ãã«ã¡ã¯ãã³ã«é£ã³ã€ãããã®ã¯ãããšããšã¯ã¯ã¯ãã³ãžã®å察ã§ã¯ãªããã¯ã¯ãã³äžè¶³ã ã£ã
>äžçåå°ã§äººã ãã€ãã«ã¡ã¯ãã³ã«é£ã³ã€ãããã®ã¯ãããšããšã¯ã¯ã¯ãã³ãžã®å察ã§ã¯ãªããã¯ã¯ãã³äžè¶³ã ã£ã
ã€ãã³ã¡ãã
ãæ¢åã®çšæ³çšéã§ãªãã€ãã«ã¡ã¯ãã³ã®å®å šæ§ã ãã¯æºãããªããã ããææãããã¿ããªã§é£²ãã§èŠããããã ãã®è©±ãªã®ã«ããªã飲ãããšèªäœãé»æ¢ããããšããã®ããã
â ããããã®æå¯çè«è¬ãšããŠäœ¿ããã人ãå ¥æå°é£ã«ãªã£ãŠå°ã£ãŠãããã ã
ãæ¢åã®çšæ³çšéã§ãªãã€ãã«ã¡ã¯ãã³ã®å®å šæ§ã ãã¯æºãããªããã ããææãããã¿ããªã§é£²ãã§èŠããããã ãã®è©±ãªã®ã«ããªã飲ãããšèªäœãé»æ¢ããããšããã®ããã
â ããããã®æå¯çè«è¬ãšããŠäœ¿ããã人ãå ¥æå°é£ã«ãªã£ãŠå°ã£ãŠãããã ã
æ±äº¬éœå»åž«äŒã®äŒé·ãèšåããŠããã€ãã«ã¡ã¯ãã³ãããããèšäºãèžãŸããŠãç§åŠçã«ãç¶ç¶ããŠæ
å ±çºä¿¡ããŠããã ãããã§ããã
çå®ãã¡ãã£ã¢ã®åŠæ¹ç®ã¯æãããã
æ å ±æäœã¯ææã§å·Šå³ãããè¯å¿ãæ£çŸ©ãéã«ç©ãŸãããããµãã€ãã«ã®æ代ãèªå·±å€æãææãåããã
æ å ±æäœã¯ææã§å·Šå³ãããè¯å¿ãæ£çŸ©ãéã«ç©ãŸãããããµãã€ãã«ã®æ代ãèªå·±å€æãææãåããã
ã€ãã«ã¡ã¯ãã³ã¯äœå幎ã䜿ãããé§è«è¬ã§ãð
ãããåã®mRNAã¯ã¯ãã³ã¯æ²»éšã§ãð
æ»äº¡ãé節è ãå¯åå¿ã調ã¹ãããã®äººäœå®éšã§ãð±
èªçŽæžã«æžããŠãŸãããâïž
çèâ ïž
ãããåã®mRNAã¯ã¯ãã³ã¯æ²»éšã§ãð
æ»äº¡ãé節è ãå¯åå¿ã調ã¹ãããã®äººäœå®éšã§ãð±
èªçŽæžã«æžããŠãŸãããâïž
çèâ ïž
BBCã®èšäºãåèš³ãåºãŠããŸãããåºãèªãŸããŠã»ããã§ããã
ã€ãã³ã¡âBBCã¯ã¯ã¯ãã³ã¯å®å
šã ãšã°ããèšã£ãŠãã¯ã¯ãã³ã®å¯åå¿ã«ã€ããŠã¯ãã¯ã«å ±éããªããããã€ãã€ãä¿¡çšåºæ¥ãªããªãã¯ã¯ãã³æ¥çš®åªççåœã®ã€ã¹ã©ãšã«ã®æšç¶ã«ã€ããŠã¯ã©ãèããŠããã®ã ãããïŒ
äºé²ã«é±äžã§é£²ãã§ããšããäœã察çããªãããã¯ãã·ãšã奜æçã«æã£ãŠã人ã®ã³ã¡ã³ãå€ãããéçœã®æã®ãšãŠçŽ å€ã¿ããã ãªãšå人çã«æã£ãŠãã
ã©ããªè¬ãçŸç
ã暩åšããè«æã§ç殺äžå¥ªã¯èªç±èªåšâŠãšããã®ãã³ããçŠã§ããã£ããå®éã¯ä»æäžæ¬ããå»è¬åã¡ãŒã«ãŒèåãåœå
æ²»éšéå§ã§ãã
â
â
æãåœã®ããŒãã«è³åè³è¬ã€ãã«ã¡ã¯ãã³ãäžèœè¬æ±ãããã®ã¯å®³ãçã¿ãŸããæãæåãªåè«ã¯ãã®è¬ãåæ¥åããç±³Merck瀟ãæ°åã³ãããŠã€ã«ã¹ã®äž»èŠãããã¢ãŒãŒé»å®³å€ãéçºããŠããããšã§ãã
æšæ¥ãã話é¡ã ãw
æåŸã«ã圌女ã¯æªåãå§ãããšãé©åãªæ€æ»ãæ²»çãåãããã€ãã«ã¡ã¯ãã³ã§èªåãæ²»çããããšããäžäŸã
æªåããŠãã飲ãã§ãæå³ãç¡ãã®ã«ãã€ãã«ã¡ã¯ãã³ã®å¹æããªãã£ãã±ãŒã¹ãšããŠæžãã®ã¯ããããã
æåŸã«ã圌女ã¯æªåãå§ãããšãé©åãªæ€æ»ãæ²»çãåãããã€ãã«ã¡ã¯ãã³ã§èªåãæ²»çããããšããäžäŸã
æªåããŠãã飲ãã§ãæå³ãç¡ãã®ã«ãã€ãã«ã¡ã¯ãã³ã®å¹æããªãã£ãã±ãŒã¹ãšããŠæžãã®ã¯ããããã
ãªãã»ã©ãã³ããã«ã€ãã«ã¡ã¯ãã³ã£ãŠãã話ã¯ã¯ã¯ãã³ã®äžè¶³ã«ããäžå®ããå§ãŸã£ãã®ã
ãã°ã«ãŒãã®äžéšã«ã¯ãã€ãã«ã¡ã¯ãã³ãããã£ãŠé èœããªãããŠãããšããé°è¬è«ãå®æçã«æçš¿ããããåã¯ã¯ãã³ææ
ãé«ããããã€ãã«ã¡ã¯ãã³ãåºããªãç
é¢ããã¯å»ãããå§åãããããæçš¿ãã¿ãããã
æèŠã®åããããšãããªãã§ãããããã¡ãŒã«ãŒãç§åŠçã§å
¬çãªæ©é¢ãèªããŠããªããã®ãå§ãã以äžãäœããã®æ°ããç 究ææã瀺ãããã¹ãã ãšæããŸãã
å人茞å
¥ããŠã人ã沢山èŠããããªãã»ã»ã»
åã¯ã¯ã®ã³ã¡ã³ããããããªãïŒã¿ïŒ
ã€ãã³ã¡ãé
·ãããã
çµå£è¬ã¯ãã£ãšã¢ã«ããã©ãã«ãã§ããã°ããã
ããã¯ã€ãã«ã¡ã¯ãã³ ãšã¯å šãéã(å¿œé£å çã®æžããèšäºãã
飲ã¿è¬ã¯ãä»ãæ¥æ¬ã«ãªãã®ïŒ
çµå£è¬ã¯ãã£ãšã¢ã«ããã©ãã«ãã§ããã°ããã
ããã¯ã€ãã«ã¡ã¯ãã³ ãšã¯å šãéã(å¿œé£å çã®æžããèšäºãã
飲ã¿è¬ã¯ãä»ãæ¥æ¬ã«ãªãã®ïŒ
æ¬åœã«ãç²ãæ§ã§ãã
ããããšãããããŸãã
ã€ãã«ã¡ã¯ãã³ã泚ç®ãããŠããŸãã
泚ç®ãããŠãŠç®ãé¢ããªãã§ãã
ããããšãããããŸãã
ã€ãã«ã¡ã¯ãã³ã泚ç®ãããŠããŸãã
泚ç®ãããŠãŠç®ãé¢ããªãã§ãã
éœç¥äºéžã»éœè°éžã»è¡è°é¢éžæãšãåã¯ã¯ãã³ ããŒãã¹ã¯ãã®åè£è
ãããããããã¹ã³ãã¯ãããåã³è
°ã«ã
æ¥æ¬ã§ã¯æäœã«ã¯ãã«çæ³ãåºãããã
ç§åŠã¯å®æã ãä»çŸåšãäœããããããããªããªã£ããé§ã®äžãææ¢ãã§é²ãã§çããŠããç¶æ
ãããšããŒã¬ã³ã³å士ã泚ææžãããŠãããã©ã銬çšã®ã€ãã«ã¡ã¯ãã³ã飲ãã ãã飲ã¿æ¹ãééãããã ãã ãããããã人ã¯è¢«å®³åºãŠããã
ã¡ã«ã¯ãèªç€Ÿéçºã®æ°è¬ã売ãããããã«ã»ã»ã»ïŒåŸã¯èªéïŒ
ã€ãã«ã¡ã¯ãã³ã«ã€ããŠãæ°åã³ãããŠã€ã«ã¹ææçã®æ²»çè¬ãšããŠã®æå¹æ§ãçŸæç¹ã§ã¯èšŒæãããŠããªãããšãäŒããBBCæ¥æ¬èªçã®èšäºã
ããã®ã³ã¡ã³ãæ¬èŠããšãæäžã«åºãŠããå士ãšåãããã©ããªèšŒæ ãæ瀺ãããŠãä¿¡ããªããã ãããªã
ããžãã»ã»
å°ŸåŽããã¯ã©ãæããŠããã ããã
"4人ã¯ãã³ãããã¯ã®æäžãéå ¬åŒãã€èªçºçã«ãé éã§å ±ã«èª¿æ»ã«ããã£ãŠãã"ã£ãŠãåããã
å°ŸåŽããã¯ã©ãæããŠããã ããã
"4人ã¯ãã³ãããã¯ã®æäžãéå ¬åŒãã€èªçºçã«ãé éã§å ±ã«èª¿æ»ã«ããã£ãŠãã"ã£ãŠãåããã
äœãæ¬åœã§äœãåããµãããªåãããªããäºé²ã®çºã«ã€ãã«ã¡ã¯ãã³ãå§ãããããã©ãå
¥æå°é£ãªç¶æ³ã§ããããé«é¡ã§è³Œå
¥ããŠãŸã§é£²ãããšã¯æããªãã
ããã ãäžå¯§ã«æžãããŠãèšäºãèªãŸãã«ãæ°æã¡å
šéã³ã¡ã³ãä»ãã¡ããã®ãã€ãã«ã¡ã¯ãã³ä¿¡è
ãªãã ããªã
æ£ããæ²»éšç¢ºèªãåŸ
ã€ããããã®ïŒè¿éããããªããŠå¹»æ³ã¯äžå¹žãæãã
è±æšææãçããŸãç²ãæ§ã§ãâïž
ãç¥ããããŸãã
ã€ãã«ã¡ã¯ãã³ ã®BBCã®ãã¥ãŒãYahooãã¥ãŒã¹ã«ãªããŸããã
æ©ãã§ãâïž
ãç¥ããããŸãã
ã€ãã«ã¡ã¯ãã³ ã®BBCã®ãã¥ãŒãYahooãã¥ãŒã¹ã«ãªããŸããã
æ©ãã§ãâïž
ã€ãã«ã¡ã¯ãã³ã®äœçšæ©æ§èãããšãèªåçšåºŠã®å»åŠç¥èã§ãããŸããŠã€ã«ã¹ã«å¹ããšã¯èããããªã(ãã©ãæ²»éšããŒã¿ãèŠãªããšæçµå€æã¯é£ãã)ãã£ãŠãªããããã©ãªãâŠã
ãªã³ã¯å
ã¯BBCãµã€ãã§ããã転èŒãããã€ããŒãã¥ãŒã¹ïŒè²ŒããŸããïŒã®ã³ã¡ã³ãã«ã¯ãèªåã®ä¿¡ããããã®ãä¿¡ãããæ¹ã
ãèéããŠãŸããããèŠåŽãªããšã ã
ã³ããäºé²ã¯èªç¶å
ç«æŽŸã ããã€ãã«ã¡ã¯ãã³ã«ã¯èå³ããªãã
ããããæšå¥šãããŠããã¢ãã«ãããã¡ã€ã¶ãŒã¯ã¯ãã³ãæ°å¹ŽåŸåãŒãè¬å®³ãåé¡ã«ãªãã ããã
æ¹å€ã®çå ãæ°è¬ã«åããèšäºã«æããã
ããããæšå¥šãããŠããã¢ãã«ãããã¡ã€ã¶ãŒã¯ã¯ãã³ãæ°å¹ŽåŸåãŒãè¬å®³ãåé¡ã«ãªãã ããã
æ¹å€ã®çå ãæ°è¬ã«åããèšäºã«æããã
溺ããè
ã«èãæŽãŸããææ¥ãããâŠ
ããŒãŒã
ãã€ãã«ã¡ã¯ãã³ãCOVID-19ã«ããæ»ãé²ãããšã瀺ããããšäž»åŒµããèšåºè©Šéšã®äžã«ããæãããªæé ïŒãã€ããïŒã®å
åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ãããšè¿°ã¹ããã
ã³ã¡ã³ãæ¬ãèŠãããåã¯ã¯ãã³ã»ã€ãã«ã¡ã¯ãã³ã®æ¯æè
ããããªãã£ãã®ã§ç©æããã
ããã ã説æãããŠããã€ãã«ã¡ã¯ãã³ä¿¡è
ãã³ã¡æ¬ã«å€§éã«æ²žããŠãã®ããããªã
ãã®è«èª¿ãå¢ããŠããŠãããããŠBBCã¯ä¿¡çšåºæ¥ããšæã£ãŠãŸãã
ãã®è«èª¿ã確å®ããåŸã«åœå ã®ã€ãã«ã¡ã¯ãã³æ¯æããŠã人ã¯ãã©ãããèšãèš³ããã®ãã
ãã®è«èª¿ã確å®ããåŸã«åœå ã®ã€ãã«ã¡ã¯ãã³æ¯æããŠã人ã¯ãã©ãããèšãèš³ããã®ãã
ã€ãã«ã¡ã¯ãã³ã¯å¹æãªã
ãã€ãã«ã¡ã¯ãã³ãCOVID-19ã«ããæ»ãé²ãããšã瀺ããããšäž»åŒµããèšåºè©Šéšã®äžã«ããæãããªæé ïŒãã€ããïŒã®å åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ãããšè¿°ã¹ãã
ãã€ãã«ã¡ã¯ãã³ãCOVID-19ã«ããæ»ãé²ãããšã瀺ããããšäž»åŒµããèšåºè©Šéšã®äžã«ããæãããªæé ïŒãã€ããïŒã®å åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ãããšè¿°ã¹ãã
å°ŸåŽæ±äº¬éœå»åž«äŒé·ãšïŒé£ãã¹ã¿ãŒãäœæããæŠèµéåžé·ã100åãšãŸã§ã¯èšããªããã10åã¯èªãã§é ãããã
ã¡ã«ã¯ã®æ°ããé«é¡ãªæ²»çè¬ã売ãããããã«ã€ãã«ã¡ã¯ãã³ãå¹ããªããšèšã£ãŠããã ãšåãæ¢ããŠã人ãå°ãªãããããã®ãâŠã
èªåçšã¡ã¢
BBCããã€ãã«ã¡ã¯ãã³ã®ãããææããèšäºãåºããŸããã
å€æææããèªåã®äžãã«ãã人ãç§åŠè
ãåä¹ã£ãŠããã®ã¯æãããâŠâŠãèªå·±å€æã£ãŠã®ã¯æã蟌ã¿ãšã®æŠãã§ããã人éã¯å®¹æã«è² ããããã ããåã¯ã¯ãã³ã®é£äžèŠãŠãŠå確èªããã
ïŒã¢ã¡ãªã«ãã€ã®ãªã¹ã欧å·é£åïŒEUïŒã®ä¿å¥åœå±ã¯ã€ãã«ã¡ã¯ãã³ã«ã€ããŠãCOVID-19察çãšããŠäœ¿çšããã«ã¯ååãªèšŒæ ããªããšå€æããã
ããã¯é
·ãã
"COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã"
"COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã"
ã€ãã«ã¡ã¯ãã³ãæšå¹Žæµè¡ã£ãããããã·ã¯ãããã³ããSimone Goldãšããå»è
ãç©æ¥µçã«æšããŠããã
ãã®å»è ã¯Americaâs frontline doctorsãšããå³ç¿Œç³»ãã©ã³ã掟ã®æ¿æ²»å£äœã®èšç«è ã§ãããã
çµæãšããŠãè¬ãæ¿æ²»æèãåæ ãããšããäžæè°ãªçŸè±¡ãèµ·ãã£ãŠããšæšæž¬
ãã®å»è ã¯Americaâs frontline doctorsãšããå³ç¿Œç³»ãã©ã³ã掟ã®æ¿æ²»å£äœã®èšç«è ã§ãããã
çµæãšããŠãè¬ãæ¿æ²»æèãåæ ãããšããäžæè°ãªçŸè±¡ãèµ·ãã£ãŠããšæšæž¬
"BBCã®åæã§ããã®è¬ãæšé²ããŠãã人ã
ãæ ¹æ ãšããŠããå€ãã®éèŠãªç 究ã«ã¯ãæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠãã"
倧æãã¥ãŒã¹ã¡ãã£ã¢ãããã£ãšã€ãã«ã¡ã¯ãã³ãCCPãŠã€ã«ã¹ã«å¹æãç¡ãããšãå ±ããŸããã
ã©ããæé ãšãé°è¬ãšãèšããã ãããâŠ